Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 4,538	$ 5,706
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	933	997
Depreciation and amortization	385	376
Net change of deferred loan origination costs	413	229
Net amortization of premiums & discounts on available-for-sale securities	(1,044)	(225)
Accretion of purchase accounting marks on loans	(235)	(831)
Amortization of core deposit intangible	390	435
Accretion of premium on FHLB advances	(23)	(38)
ESOP compensation expense	93	66
Earnings on bank owned life insurance	(42)	(43)
Net change in assets and liabilities:
Deferred tax assets	1,238	1,492
Accrued interest receivable	(965)	(601)
Other assets	(677)	(995)
Accrued expenses and other liabilities	2,287	(461)
Net cash provided by operating activities	7,594	6,324
Cash flows from investing activities:
Net change in loans receivable held for investment	(115,331)	(119,928)
Principal payments and maturities on available-for-sale securities	18,395	19,325
Purchase of available-for-sale securities	0	(215,500)
Purchase of FRB stock	0	(4,571)
Purchase of FHLB stock	(13,287)	(5,414)
Proceeds from redemption of FHLB stock	8,667	2,452
Proceeds from redemption of FRB stock	1,720	0
Purchase of office properties and equipment	(208)	(323)
Net cash used in investing activities	(100,044)	(323,959)
Cash flows from financing activities:
Net change in deposits	(4,281)	(101,136)
Net change in securities sold under agreements to repurchase	10,004	11,511
Increase in unreleased ESOP shares	(3,400)	(500)
Proceeds from issuance of preferred stock	0	150,000
Proceeds from Bank Term Funding Program	100,000	0
Dividends paid on preferred stock	0	(15)
FDIC stock repurchase	(1,781)	0
Proceeds from FHLB advances	456,138	95,500
Repayments of FHLB advances	(375,140)	(53,140)
Net cash provided by financing activities	181,540	102,220
Net change in cash and cash equivalents	89,090	(215,415)
Cash and cash equivalents at beginning of the period	16,105	231,520
Cash and cash equivalents at end of the period	105,195	16,105
Supplemental disclosures of cash flow information:
Cash paid for interest	16,921	3,053
Cash paid for income taxes	2,036	332
Supplemental non-cash disclosures:
Common stock issued in exchange for preferred stock	0	3,000
Assets acquired (liabilities assumed) in acquisition:
Goodwill	0	(138)
Deferred taxes	0	138
Employees, Excluding Directors [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	208	133
Directors [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	$ 95	$ 84